Oncology Institute regains Nasdaq minimum bid price compliance

Oncology Institute, Inc.

Received Nasdaq notice on Sept 15, 2023 confirming compliance with Listing Rule 550(a)(2).
Common stock closing bid price was $1.00 or more for 11 consecutive business days through Sept 14.
Company had been non-compliant since April 25, 2023; original deadline was Oct 23, 2023.

item 8.01 item 9.01

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001799191-23-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.